Lisa Blanchette Email & Phone Number

Fort Myers, FL, US

• Specialty Representative
• Medical Device/VNS Clinical Trial
• Inventory Specialist
• Inventory/Storage Site Inspections/Closeouts
• LivaNova alliance to generate awareness, educate prescribers, recruit investigators and screen patients for VNS Therapy Clinical Trial nationwide
• Bayer collaboration to retrieve and return Essure Devices from healthcare practices

• Marketed Major Depressive Disorder to Psychiatrists, hospitals, mental health centers and pharmacists. Collaborated with Otsuka sales team in the territory launch of Rexulti. Partnered with Takeda sales team in the.
• Spearheaded 4.30% increase in new prescription market share for 2018 3rd trimester Rexulti Schizophrenia Initiative.
• Ranked 20/189 (11%) in Aug and 41/189 (22%) in July for 2018 National Portfolio Rankings.
• Increased Rexulti prescribers 45% as part of the company’s 2017 2nd trimester Rising Tide initiative.
• Ranked 24/189 (13%) Nation for Rexulti Aug 2018 which was 23% growth in 2 months.
• Elevated targets 102% during 2017 3rd trimester MidAtlantic LIS Regional initiative.

• Responsible for promoting Women’s Health to Primary Care, Internal Medicine, Gynecologists, Urogynecologists, and Urologists. Managed a range of products including Osphena, Naprelan and Brisdelle.Key Achievements:
• Achieved 8 prescribers, 8 weeks, 31 new prescriptions by implementing speaker program.
• Launched Osphena in women's health market, generating new business and scripts in 6 months.
• Ranked 16/75 (20%) Nation, 2/21 (10%) Region, 15/75 (20%) Growth in August 2014.
• Achieved 9 new prescribers, 4 weeks, 19 new prescriptions in Expand the Base Contest in 11/2013.
• Achieved multiple incentive awards based on entrepreneurial spirit, transparent communication, market share growth and new prescribers.

• Spearheaded efforts to promote Insomnia and Respiratory to Primary Care, Internal Medicine, Pulmonologists, Psychiatrists, Pain Management, Neurologists, Rheumatologists, Allergists and Hospitals. Peer Champion and.
• Gained addition of Lunesta to Medicaid formulary for 3 years by cultivating relationships with key opinion leaders influential on managed care issues.
• Ranked in the top 25% of the nation for launching 4 products over a 4-year period including Lunesta, Xopenex HFA, Brovana and Omnaris.
• Consistently achieved 100% or greater for all products in 2010 ranking in the top 25% company-wide and top 15% in 2011.
• Received Prism Honors Award Gold Member 2012 for ranking within top 10% of entire sales force.
• Achieved Territory Sales Partner of the Year in 2005 and 2007.

• Promoted Diabetes, Cardiovascular, Nuclear Imaging, and Antibiotics to Primary Care, Endocrinologists, Cardiologists, and hospitals. Managed a diverse product portfolio including Coumadin, Cardiolite, Innohep.
• Generated 5 coumacare sites which resulted in exceeding quota attainment.
• Increased tablet volume by 300,000 per year and exceeding quota 200% by converting hospital to brand Coumadin.
• Attained 128% increase vs. previous year by converting 6 hospitals to Cardiolite.
• Achieved script volume of 125% by championing efforts to launch Metaglip in 2002.
• Raised product awareness which led to increased prescriptions by facilitating Medical Education Programs for physicians, nurses, pharmacists, and diabetes educators.